The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Professional NewsFull Access

More Seniors Receive Psychotropics

Published Online:https://doi.org/10.1176/pn.44.13.0012a

A study published in the May/June Health Affairs finds that more health care providers are prescribing psychotropic medications to their patients, particularly to seniors.

In an analysis of U.S. mental health care trends from 1996 through 2006, Sherry Glied, Ph.D, and Richard Frank, Ph.D., found that the number of seniors receiving psychotropic drug prescriptions doubled during that time period.“ Greater availability of medications to treat conditions like Alzheimer's and increased access to prescription drugs through the Medicare Modernization Act may have also played a role in doctors' prescribing drugs to seniors,” said Glied, a professor and chair of health policy and management at Columbia University's Mailman School of Public Health. Frank is a professor of health economics at Harvard Medical School (see Original article: Unbalanced MH System Needs Major Shift in Focus).

“Trends in Mental Health Cost Growth: An Expanded Role for Management?” is posted at<http://content.healthaffairs.org/cgi/content/abstract/28/3/637>.